Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Licensing and Other Arrangements - Janssen (Details)

v3.24.2.u1
Acquisitions, Licensing and Other Arrangements - Janssen (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Aug. 31, 2019
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2019
Dec. 31, 2023
Licensing and other arrangements              
Revenue from contracts with customers   $ 5,025 $ 1,125 $ 6,025 $ 1,125    
Janssen | License Agreement              
Licensing and other arrangements              
Cash payment received $ 2,500            
Maximum eligible milestone payments receivable per discovery product candidate $ 3,000            
Percentage of royalty on sales 0.75%            
Revenue from contracts with customers   0 $ 1,100 0 $ 1,100 $ 2,500  
Contract assets   0   0     $ 0
Contract liabilities   0   0     0
Capitalized contract costs   $ 0   $ 0     $ 0